Martin Dreyling, MD¹, Jiri Mayer, MD², David Belada, MD, PhD³, Yuqin Song, MD⁴, Wojciech Jurczak, MD, PhD⁵, Jonas Paludo, MD⁶, Michael P. Chu, MD⁷, Iryna Kryachok, MD^8*, Laura Maria Fogliatto, MD^9*, Chan Y. Cheah, MBBS DMSc¹⁰, Marta Morawska, MD, PhD^11,12*, Juan-Manuel Sancho, MD, PhD^13*, Yufu Li, MD^14*, Caterina Patti, MD^15*, Cecily Forsyth, MD¹⁶, Jingyang Zhang, PhD^17*, Robin Lesley, PhD^17*, Safaa Ramadan, MD, PhD^18*, Simon Rule, MD^19* and Michael Wang, MD²⁰

¹Medizinische Klinik III, Klinikum der Universitaet Munchen, Muenchen, Germany
²Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
³4th Department of Internal Medicine – Haematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
⁴Key Laboratory of Carcinogenesis and Translational Research, Department of Lymphoma, Peking University Cancer Hospital, Beijing, China
⁵Department of Clinical Oncology, Malopolskie Centrum Medyczne S.C, Krakow, Poland
⁶Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁷Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁸Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine
⁹Department of Clinical Hematology, Hospital das Clínicas de Porto Alegre, Porto Alegre, Brazil
¹⁰Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
¹¹Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland
¹²Hematology Department, St. John’s Cancer Center, Lublin, Poland
¹³Clinical Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain
¹⁴Department of Hematology, Henan Cancer Hospital, Zheng Zhou, China
¹⁵Oncohematology Unit, A.O.O.R. Villa Sofia Cervello, Palermo, Italy
¹⁶Central Coast Haematology, North Gosford, Australia
¹⁷AstraZeneca, South San Francisco, CA
¹⁸AstraZeneca, Cambridge, United Kingdom
¹⁹Executive Director, Haematology R&D, AstraZeneca, Cambridge, United Kingdom
²⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Joshua Brody, MD^1*, Lorenzo Falchi, MD², Umberto Vitolo, MD³, Marcel Nijland, MD, PhD^4*, Fritz Offner, MD, PhD⁵, Sylvia Snauwaert, MD, PhD^6*, Poliana Patah, MD, PhD^7*, Jennifer Marek^8*, Christopher Morehouse, MS^8*, Andrew J. Steele, PhD^8*, Yi Hao, DrPH^8*, Daniela Hoehn, MD, PhD^8* and Kim Linton^9*

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin), Italy
⁴University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⁵Universitair Ziekenhuis Gent, Gent, Belgium
⁶Department of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium
⁷AbbVie, North Chicago, IL
⁸Genmab, Plainsboro, NJ
⁹The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom

Stefano Luminari¹, Jose C. Villasboas Bisneto, MD², Geoffrey Chong^3*, David Tucker⁴, Srikanth Ambati⁵, Chinjune Lin⁵, Hesham Mohamed⁵, C. Akunna Otele^5*, Giovanni Antico^5* and Ana Jiménez Ubieto^6*

¹Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
²Mayo Clinic, Rochester, MN
³Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
⁴Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁶Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Patrizia Mondello, MD, PhD, MSc¹, Brianna J Negaard, MS^2*, Andrew L. Feldman, MD³, Brian K. Link, MD^4*, Carla Casulo, MD⁵, Dai Chihara, MD, PhD⁶, David A Russler-Germain, MD, PhD⁷, Jason Romancik^8*, Caitlin Gribbin, MD^9*, Sara Haddadi^10*, Eric Mou, MD^4*, Ivana N. Micallef^1*, Patrick B. Johnston, MD, PhD^11*, Anne J. Novak, PhD¹, Yucai Wang, MD, PhD¹, Rebecca L. King, MD^3*, Thomas M. Habermann, MD¹, Peter Martin, MD⁹, Grzegorz S. Nowakowski, MD¹¹, Loretta Nastoupil^6*, James R. Cerhan, MD, PhD¹², Christopher R. Flowers, MD, MS⁶, Izidore S. Lossos, MD¹⁰, Richard Burack, MD, PhD¹³, Matthew J. Maurer, DSc^2* and Stephen M. Ansell, MD, PhD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁵Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁸Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, Georgia
⁹Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
¹⁰Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
¹¹Mayo Clinic, Rochester, MN
¹²Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹³Pathology and Laboratory Medicine, University of Rochester, Rochester, NY

Yanan Zhu^1*, Yunfei Lv^2*, Xingnong Ye^2*, Juying Wei^2*, Lixia Sheng^3*, Ying Lin^4*, Xiang Zhang^2*, Xuewu Zhang^2*, Hongyan Tong², Jie Jin, M.D.⁵ and Wen-Juan Yu^1*

¹The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
³Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
⁴The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
⁵Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Tycel J. Phillips, MD¹, Marek Trněný², Carmelo Carlo-Stella, MD³, Jan Maciej Zaucha^4*, Tomasz Wrobel^5*, Fritz Offner, MD, PhD⁶, Michael J. Dickinson, MBBS, DMedSci⁷, Monica Tani^8*, Michael Crump, MD^9*, Nancy L. Bartlett, MD¹⁰, Joaquín Martínez-Lopez^11*, Paolo Corradini, MD¹², Estefania Mulvihill^13*, Alessia Bottos, PhD^13*, Derrick Kaufman^14*, James Relf^15*, Fabiola Bene Tchaleu^14*, Alexandra Bazeos^15*, Linda Lundberg^13* and Franck Morschhauser, MD, PhD¹⁶

¹City of Hope National Medical Center, Duarte, CA
²Charles University, Prague, Czech Republic
³Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
⁴Medical University of Gdańsk, Gdańsk, Poland
⁵Wroclaw Medical University, Wroclaw, Poland
⁶Universitair Ziekenhuis Gent, Gent, Belgium
⁷Peter MacCallum Cancer Centre, Melbourne, Australia
⁸Ospedale Santa Maria delle Croci, Ravenna, Italy
⁹Princess Margaret Hospital, Toronto, ON, Canada
¹⁰Siteman Cancer Center, Washington University, St. Louis, MO
¹¹Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, imas12, Madrid, Spain
¹²University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
¹³F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵Roche Products Ltd, Welwyn, United Kingdom
¹⁶Centre Hospitalier Universitaire de Lille, Lille, France

Yuankai Shi^1*, Jianliang Yang^1*, Yongping Song^2*, Keshu Zhou^3*, Zhiming Li, PhD, MD⁴, Mingzhi Zhang, MD⁵, Hongmei Jing⁶, Zhen Wang, MD^7*, Li Yu^8*, Wei Meng^9*, Qiying Lu^9* and Wenzhi Tian^9*

¹Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
²Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
³Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
⁵The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁶Peking University Third Hospital, Beijing, CHN
⁷Linyi Cancer Hospital, Linyi, China
⁸The Second Affiliated Hospital of Nanchang University, Nanchang, China
⁹ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China

Paolo Lopedote, MD¹, Geoffrey Shouse, PhD, DO², Alexandra Muir, BSN, RN^3*, Carly Rolender^3*, Peter Sportelli, BS⁴, Hari Miskin, MSc^4*, Lu Chen, PhD^5*, Tycel Phillips, MD^6* and Alexey Danilov, MD, PhD⁷

¹Department of Hematology and Medical Oncology, City of Hope National Medical Center, Duarte, CA
²City of Hope Cancer Center, Duarte, CA
³City of Hope National Medical Center, Duarte
⁴TG Therapeutics, Inc., New York, NY
⁵Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
⁶Department of Hematology and Oncology, City of Hope, Duarte, CA
⁷City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA

Wojciech Jurczak, MD, PhD¹, Isabelle Fleury, MD, MSc², Antonio Pinto^3*, Sanne Lugthart, MD^4*, Omur Gokmen Sevindik, Prof⁵, Iryna Kryachok, MD^6*, Elizabeth Phillips, MD⁷, Fei Li⁸, Chan Y. Cheah, MBBS DMSc⁹, Jing Yang, DMD^10*, Yan Xu^10*, Siyang Leng, MD, MS^10* and Fangfang Lv^11*

¹Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
²Hôpital Maisonneuve – Rosemont, Montreal, ON, Canada
³Struttura Complessa Ematologia Oncologica, Napoli, Italy
⁴University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom
⁵Istanbul Medipol University, International School of Medicine, Istanbul, Turkey
⁶Oncohematology, National Cancer Institute, Ukraine Hemoblastoses of Division of Conservative Methods of Treatment, Kyiv, Ukraine
⁷The Christie NHS Foundation Trust, Manchester, United Kingdom
⁸Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
⁹Linear Clinical Research and Hollywood Private Hospital, Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, Western Australia, Australia
¹⁰Merck & Co., Inc., Rahway, NJ
¹¹Fudan University, Shanghai, China

Yuqin Song, MD¹, Qingqing Cai, PhD², Keshu Zhou, MD^3*, Ming Jiang^4*, Zhengming Jin, M.D.^5*, Lei Zhang, PhD, MD^6*, Xiuhua Sun^7*, Haiyan Yang^8*, Lanfang Li^9*, Kaiyang Ding^10*, Junyuan Qi, MD^11*, Hongmei Jing^12*, Wei Yang^13*, Min Zhou^14*, Jun Ma^15*, Zhigang Peng^16*, Wei Xu^17*, Hui Zhou, MD¹⁸, Li Yu^19*, Yuankai Shi, MD^20*, Guohui Cui^21*, Zheng Wang^22*, Nawei Liu^22*, Yejiang Lou, PhD^23*, Yue Shen, PhD^22*, Yi Chen, PhD^24*, Fenlai Tan^22* and Jun Zhu, MD^25*

¹Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
³Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China
⁵Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁶The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
⁷The Second Hospital of Dalian Medical University, Dalian, China
⁸Zhejiang Cancer Hospital, Hangzhou, China
⁹Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹⁰Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
¹¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
¹²Department of Hematology, Peking University Third Hospital, Beijing, China
¹³Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
¹⁴Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
¹⁵Harbin Institute of Hematology & Oncology, Harbin, China
¹⁶The First Affiliated Hospital of Guangxi Medical University, Nanning, China
¹⁷Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
¹⁸Department of Lymphoma & Hematology, Hunan Cancer Hospital and Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
¹⁹The Second Affiliated Hospital of Nanchang University, Nanchang, China
²⁰Cancer Hospital (Institute), CAMS & PUMC, Beijing, China
²¹Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²²Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
²³Guangzhou Lupeng Pharmaceutical Co., Ltd., Hangzhou, China
²⁴Newave Pharmaceutical Inc., Pleasanton, CA
²⁵Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Minis-try of Education), Peking University Cancer Hospital & Institute, Beijing, China

Hyungwoo Cho, MD^1*, Dok Hyun Yoon, MD, PhD², Jason Yongsheng Chan³, Dajung Kim, MD^4*, Haiwen Huang, MD^5*, Qingqing Cai, PhD⁶, Tongyu Lin^7*, Koji Kato, MD, PhD⁸, Udomsak Bunworasate, MD^9*, Sen Mui Tan^10*, Ka-Won Kang, MD, PhD^11*, Jae-Yong Kwak^12*, Tsai-Yun Chen^13*, Jeong-Ok Lee, MD¹⁴, Seong Hyun Jeong, MD^15*, Young Rok Do, MD, PhD¹⁶, Esther Chan^17*, Hye Jin Kang^18*, Hyun-Seok Uhm^19*, Sung Yong Oh^20*, Youngil Koh, MD, PhD²¹, Hyo Jung Kim^22*, Se Hyung Kim, MD^23*, Jong Ho Won^24*, Young Hoon Park^25*, Deok-Hwan Yang, MD, PhD^26*, Soo Chin Ng, FRCP²⁷, Jae-Cheol Jo, MD, PhD²⁸ and Won Seog Kim, MD^29*

¹Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
⁴Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
⁵National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
⁶Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁷Sichuan Cancer Hospital, Guangzhou, China
⁸Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
⁹Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
¹⁰Department of Hematology, Ampang Hospital, Selangor, Malaysia
¹¹Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
¹²Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic of (South)
¹³National Cheng Kung University Hospital Clinical Trial Center, Tainan, Taiwan
¹⁴Department of Internal Medicine, Seoul National Univ. Bundang Hospital, Seongnam-Si, None, KOR
¹⁵Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
¹⁶Department of Hemato-Oncology, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
¹⁷Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
¹⁸Korea Cancer Center Hospital, Seoul, KOR
¹⁹National Cancer Center, Goyang, Korea, Republic of (South)
²⁰Dong-A University Hospital, Busan, Korea, Republic of (South)
²¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²²Hallym University College of Medicine, Anyang, Korea, Republic of (South)
²³Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon-Si, Gyeonggi-Do, KOR
²⁴Department of Hematology-Oncology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea, Republic of (South)
²⁵Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of (South)
²⁶Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Korea, Republic of (South)
²⁷Subang Jaya Medical Center, Petaling Jaya, Selangor, MYS
²⁸Ulsan University Hospital, Ulsan, KOR
²⁹Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Jacqueline F. Wang, MD¹, Jihao Zhou, MD, PhD^2,3*, Reema K. Tawfiq, MD⁴, Han W. Tun, MD⁴, Javier L. Munoz, MD, MS, MBA⁵, Jonas Paludo, MD³, Muhamad Alhaj Moustafa, M.D., M.S.⁴, Steven R. Hwang, MD³, Izel Okcu^3*, Catherine S. Diefenbach, MD⁶, Jia Ruan, MD, PhD⁷, Peter Martin, MD⁷, Thomas M. Habermann, MD³, Thomas E. Witzig, MD⁸, Grzegorz S. Nowakowski, MD³ and Yucai Wang, MD, PhD³

¹Department of Medicine, NYU Langone Health, New York, NY
²Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁵Division of Hematology and Medical Oncology, Myao Clininc, Phoenix, AZ
⁶Perlmutter Cancer Center at NYU Langone Health, New York, NY
⁷Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁸Division of Hematology, Mayo Clinic, Stabile 628, Rochester, MN

Kossi D Abalo, PhD^1*, Trine Trab^2*, Joachim Baech, MD^3,4*, Sara Ekberg, PhD^5*, Simon Pahnke, MD^6*, Alexandra Albertsson-Lindblad, MD, PhD^7*, Karin Ekstroem Smedby, MD⁸, Mats Jerkeman, MD, PhD⁹, Peter Brown, MD, PhD^10,11*, Thomas Stauffer Larsen, MD, PhD^12,13*, Kirsten Gronbaek, MD, PhD, PR¹⁴, Tarec Christoffer El-Galaly, MD, DMSc, Prof¹⁵ and Ingrid Glimelius, MD, Professor⁶

¹Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden
²Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
³Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
⁴Department of Hematology, Clinical Cancer Research Unit, Aalborg University Hospital, Aalborg, Denmark
⁵Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institute, Stockholm, Sweden
⁶Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⁷Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden
⁸Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁹Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Skane University Hospital, Lund, Skaane Laen, Sweden
¹⁰Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen, Denmark
¹¹Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
¹²Department of Hematology, Odense University Hospital, Odense, Denmark, Odense, Denmark
¹³Department of Clinical Research, University of Southern Denmark, Odense, Denmark
¹⁴Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
¹⁵Department of Hematology, Aalborg Hospital, Aalborg, Denmark

Stefano Luminari¹, Michele Merli, MD^2*, Sara Rattotti, MD^3*, Maria Elena Nizzoli, MD^4,5*, Vittoria Tarantino, MD^6*, Simone Ferrero, MD⁷, Annalisa Talami, MD^8*, Roberta Murru, MD^9*, Marina Deodato, MD^10*, Emanuele Cencini, MD^11*, Francesca Re, MD^12*, Carlo Visco, MD^13*, Marcia Delamain, MD, PhD^14*, Michele Spina, MD^15*, Ombretta Annibali, MD^16*, Alessandro Pulsoni, MD^17*, Andrés José María Ferreri, MD¹⁸, Caterina Stelitano, MD^19*, Elsa Pennese, MD^20*, Emiliano Barbieri^5*, Stefano Pozzi, MD^4,5*, Luigi Marcheselli^21*, Francesco Merli^22*, Marco Paulli, MD^23* and Luca Arcaini^24*

¹Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
²Hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
³Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
⁴Hematology Unit, Azienda USL- IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁵Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
⁶Division of Hematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
⁷Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy
⁸Clinical and Experimental Medicine Doctorate School, Università degli Studi di Modena e Reggio Emilia, Reggio Emilia, Italy
⁹Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
¹⁰Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹¹Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
¹²Division of Hematology, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
¹³Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
¹⁴Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil
¹⁵Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
¹⁶Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
¹⁷Division of Hematology, Sapienza University – Polo Pontino, Department of Translational and Precision Medicine, S.M. Goretti Hospital, Latina, Italy
¹⁸Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁹Division of Hematology, Grande Ospedale Metropolitano, Bianchi Melacrino Morelli, Reggio Calabria, Italy
²⁰Centro diagnosi e terapia dei linfomi, Presidio Ospedaliero Spirito Santo, Pescara, Italy
²¹Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
²²Hematology Department, AZIENDA USL-IRCCS DI REGGIO EMILIA, Reggio Emilia, Italy
²³Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²⁴Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Hassan Ali, MD, MBBS^1*, Shubham Agrawal, MBBS², Satya R Durugu, MD^1*, Shrishti Sinha, MD^3*, Shammas Bajwa, MD^4*, Umair Bajwa, MBBS^5*, Rajesh Thirumaran, MD^6* and Krishna Desai^1*

¹Mercy Catholic Medical Center, Philadelphia, PA
²Masonic Cancer Center, University of Minnesota, Minneapolis, MN
³Richmond University Medical Center, Staten ISland, NY
⁴Internal Medicine Department, Oklahoma University Medical Center, Oklahoma City, OK
⁵Services Institute of Medical Sciences, Lahore, Pakistan
⁶Mercy Catholic Medical Center, Darby, PA

Sarah Mant^1*, Georgina Naylor^1*, Nicola Crosbie^1*, Sree Aroori^2*, Mark J Bishton, PhD, MBChB³, Kristian Bowles, MBBS, PhD⁴, Safia Dawi^5*, Toby A. Eyre^6*, Wendy Ingram^2*, Abigail Martin^1*, Christopher McNamara, MD^7*, Melanie Oates^8*, Andrew Pettitt, MD, PhD^8*, Claire Scully^2*, Brian Wainman^2*, Mark Warner^2*, Simon Rule, MD^9* and David John Lewis, MD^1*

¹University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
²Plymouth University, Peninsula Clinical Trials Unit, Plymouth, United Kingdom
³Nottingham University Hospitals NHS Trust, Nottingham, UK, United Kingdom
⁴Norfolk and Norwich University Hospital, Norwich, United Kingdom
⁵Hull University Teaching Trust, Hull, United Kingdom
⁶Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Old Road, United Kingdom
⁷University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁸Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
⁹Executive Director, Haematology R&D, AstraZeneca, Cambridge, United Kingdom

Julia Bannatyne Undabeitia^1*, Elia Barrio^2*, Ruben Fernandez Alvarez, MD^3*, Anabel Teruel^4*, María José Terol^5*, Sheila Bodelon^6*, Eduardo Rios Herranz, MD^7*, Victor Marco^8*, Fernando Carnicero^9*, Leonor Perez^10*, Angel Mayorales^11*, Iñigo Romon, MD, PhD^12*, Sara Fernandez-Luis, MD^13*, Enrique M. Ocio¹³ and Arancha Bermúdez^14,15*

¹Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Spain
²Hospital Universitario San Pedro, Logroño, Spain
³Hospital Universitario de Cabueñes, Asturias, Spain
⁴Hospital Clínico Valencia, VALENCIA, ESP
⁵Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
⁶Hospital del Bierzo, Leon, Spain
⁷Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
⁸Hospital Universitario San Jorge, Huesca, Spain
⁹Hospital San Pedro de Alcántara, Caceres, ESP
¹⁰Complejo Hospitalario Universitario Insular Materno Infantil, Gran Canaria, Spain
¹¹Hospital General Universitario de Ciudad Real., Ciudad Real, Spain
¹²Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Cantabria, ESP
¹³Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁴Department of Hematology, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain
¹⁵Hospital Marques de Valdecilla (IDIVAL), Santander, Spain

Oboseh John Ogedegbe, MD^1*, Asfand Yar Cheema, MD^2*, Ahmed Bashir Sukhera, MD^3*, Serhan Unlu, MD⁴, Jorge Rodriguez Vazquez, MD^3*, Gloria Erazo, MD^3* and Godfrey Tabowei^5*

¹Trinity Health Ann Arbor Hospital, Ypsilanti, MI
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Texas Tech University Health Science, Permian Basin, Odessa, TX

Adam J. Olszewski, MD^1,2, Matthew Matasar, MD, MS³, Scott F Huntington⁴, Thomas Ollila, MD^1,2, Ari Pelcovits, MD^1,5, Yun Kyoung Tiger, MD, PhD⁶, John L. Reagan, MD⁷, Anna Dorota Chorzalska, PhD^1*, John Morgan, PhD^1*, Makayla R Pardo¹, Jessica McMahon, BSN^2*, Stephen Donnelly, BS^2*, Caylee Carmody, BS, MHS^2*, Jeannine Margolis, B.Sc.^8*, Charles Milrod, MD¹ and Patrycja M. Dubielecka, PhD^1,9

¹Brown University, Providence, RI
²Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Yale School of Medicine, New Haven, CT
⁵Rhode Island Hospital, Providence, RI
⁶Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁷Brown University Health Cancer Insitute, Warren Alpert Medical School of Brown University, Providence, RI
⁸Brown University Oncology Research Group, Providence, RI
⁹Dubielecka Lab, Rhode Island Hospital, Providence, RI

Nancy L. Bartlett, MD¹, Laurie H. H. Sehn, MD², Sarit E. Assouline, MD³, Pratyush Giri, MBBS^4*, John Kuruvilla, MD, FRCPC⁵, Stephen J. Schuster^6*, Sung-Soo Yoon, M.D., Ph.D.⁷, Keith Fay^8*, Georg Hess, MD^9*, Martin Dreyling, MD¹⁰, Norma C. Gutierrez^11*, Eva Cybulski^12*, Antonia Kwan^12*, Elicia Penuel¹², Samuel Tracy^12*, Denison Kuruvilla^12*, Joseph Chen^12*, Volker Wiebking^12*, Michael C. Wei^12* and L. Elizabeth Budde¹³

¹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
²BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
³Jewish General Hospital, Montreal, QC, Canada
⁴Royal Adelaide Hospital, Adelaide, Australia
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁷Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁸St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
⁹University Cancer Center Mainz, University Medical School of the Johannes Gutenberg-University, Mainz, Germany
¹⁰Ludwig-Maximilians-University Hospital Munich, Munich, Germany
¹¹Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
¹²Genentech, Inc., South San Francisco, CA
¹³City of Hope National Medical Center, Duarte, CA

L. Elizabeth Budde¹, Matthew Matasar, MD, MS², Laurie H. H. Sehn, MD³, Sarit E. Assouline, MD⁴, John Kuruvilla, MD, FRCPC⁵, Ian W. Flinn, MD, PhD⁶, Sung-Soo Yoon, M.D., Ph.D.⁷, Francesc Bosch^8*, Daniel Greenwald^9*, Norma C. Gutierrez^10*, Dimitrios Tzachanis^11*, Paula Marlton^12*, Delaney McGuirt^13*, Shen Yin^13*, Michael C. Wei^13*, Antonia Kwan^13*, Samuel Tracy^13*, Elicia Penuel¹³ and Nancy L. Bartlett, MD¹⁴

¹City of Hope National Medical Center, Duarte, CA
²Memorial Sloan Kettering Cancer Center, New York, NY
³BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁴Jewish General Hospital, Montreal, QC, Canada
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Tennessee Oncology, Nashville, TN
⁷Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁸University Hospital Vall d’Hebron and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁹University of California, Los Angeles Health Hematology Oncology, Santa Barbara, CA
¹⁰Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
¹¹Moores Cancer Center, University of California San Diego, La Jolla, CA
¹²Princess Alexandra Hospital and University of Queensland, Brisbane, Australia
¹³Genentech, Inc., South San Francisco, CA
¹⁴Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Jorge J. Castillo, MD¹, Shayna R Sarosiek¹, Andrew R. Branagan, MD², Gottfried von Keudell, MD, PhD³, Catherine A. Flynn, NP^1*, Andres Ramirez-Gamero, MD^1*, Nina S Budano^1*, Alexandra N. Eurell^1*, Kirsten Meid, MPH^1*, Maria Luisa Guerrera, MD¹, Amanda Kofides, BA^1*, Shirong Liu, MD, PhD¹, Xia Liu, MD^1*, Kris Richardson, PhD^1*, Nickolas Tsakmaklis^1*, Christopher J Patterson, MPH, MBA^1*, Zachary R Hunter, PhD¹ and Steven P. Treon, MD, PhD, FRCP⁴

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
³Beth Israel Deaconess Medical Center, Boston, MA
⁴Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Inc., Boston, MA

Xiong Wenjie, MD^1*, Yuting Yan, MD^2*, Tingyu Wang^2*, Weiwei Sui, MD^3*, Ying Yu^1*, Tengteng Yu^2*, Rui Lyu, MD^1*, Wei Liu, MD^1*, Huimin Liu^4*, Gang An^1*, Wenyang Huang, MD^3*, Dehui Zou^1*, Lu-Gui Qiu, M.D.¹ and Shuhua Yi, MD^3*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Constantine S. Tam, MD, MBBS¹, Anna Maria Frustaci, MD^2*, Fontanet Bijou, MD³, Pier Luigi Zinzani, MD, PhD⁴, John F. Seymour, MBBS, PhD⁵, Masa Lasica, MBBS, BMedSci, FRACP, FRCPA^6*, Herbert A. Eradat, MD⁷, Victor T.G. Lin^8*, Maan Alwan^9*, Irina Mocanu, MD^10*, Xiangmei Chen^11*, Kunthel By, PhD^12*, Shannon Fabre^12*, Daniel O. Persky, MD¹², Amit Agarwal^12* and Chan Y. Cheah, MBBS DMSc^13,14,15

¹Alfred Hospital and Monash University, Melbourne, VIC, Australia
²ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
³Institut Bergonié, Bordeaux, France
⁴Institute of Hematology "Seràgnoli", University of Bologna, Bologne, Italy
⁵Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁶St Vincent’s Hospital, Melbourne, Australia
⁷David Geffen School of Medicine at UCLA, Los Angeles, CA
⁸Mary Bird Perkins Cancer Center, Baton Rouge, LA
⁹Perth Blood Institute, West Perth, Western Australia, Australia
¹⁰Institute of Oncology, ARENSIA Exploratory Medicine, Düsseldorf, Germany
¹¹BeiGene (Shanghai) Co, Ltd, Shanghai, China
¹²BeiGene USA, Inc, San Mateo, CA
¹³Linear Clinical Research, Nedlands, Western Australia, Australia
¹⁴Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
¹⁵Medical School, University of Western Australia, Perth, Western Australia, Australia

Matthew Matasar, MD, MS¹, David Tucker², Tae Min Kim, MD, PhD^3*, Stefano Luminari⁴, Yuan Cheng^5*, Jingjin Li^5*, Saleem Shariff^6*, Hesham Mohamed⁵, Srikanth Ambati⁵ and Aafia Chaudhry⁵

¹Division of Blood Disorders, Rutgers Cancer Institute and RWJBarnabas Health, New Brunswick, NJ
²Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
³Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁴Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁶Regeneron UK Ltd, Uxbridge, United Kingdom

Suheil Albert Atallah-Yunes, MD¹, Matthew James Rees, MD¹, Javier Munoz, MD^2*, Jonas Paludo, MD¹, Muhamad Alhaj Moustafa, M.D., M.S.³, Arushi Khurana, MBBS¹, Jose C. Villasboas Bisneto, MD⁴, Allison C. Rosenthal, DO⁵, Januario E. Castro, MD⁶, Madiha Iqbal, MD⁷, Mohamed A. Kharfan-Dabaja, MD, MBA⁸, N. Nora Bennani, MD¹, Paul J. Hampel, MD¹, Urshila Durani, MD, MPH¹, Patrick B. Johnston, MD, PhD^1*, Andre De Menezes Silva Corraes, MD^1*, Luis Porrata, MD¹, Stephen M. Ansell, MD, PhD¹, Yi Lin, MD, PhD¹ and Yucai Wang, MD, PhD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Mayo Clinic, Phoenix, AZ
³Division of Hematology, Mayo Clinic, Jacksonville, FL
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
⁶Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁸Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL

Carla Casulo, MD¹, Melissa C. Larson, MS^2*, Jonathan R Day, MD, PharmD³, Urshila Durani, MD, MPH⁴, Mazie Tsang, MD⁵, Jonathan W. Friedberg, MD⁶, Grzegorz S. Nowakowski, MD⁷, Jean L. Koff, MD, MSc⁸, Dai Chihara, MD, PhD⁹, Richard Burack, MD, PhD¹⁰, Thomas M. Habermann, MD⁷, Loretta Nastoupil^9*, Izidore S. Lossos, MD¹¹, Peter Martin, MD¹², Matthew Holets^13*, Brad S. Kahl, MD¹⁴, Jonathan J. Cohen, MD¹⁵, James R. Cerhan, MD, PhD¹⁶, Christopher R. Flowers, MD, MS⁹, Brian K. Link, MD^17* and Matthew J. Maurer, DSc¹⁸

¹James P. Wilmot Cancer Center, Rochester, NY
²Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
³Department of Medicine, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
⁶Wilmot Cancer Center, University of Rochester, Rochester, NY
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
¹¹Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
¹²Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
¹³Mayo Clinic, Rochester, MN
¹⁴Department of Medicine, Washington University School of Medicine, St. Louis, MO
¹⁵Department of Internal Medicine, Division of Hematology, University of Miami Hospital - Jackson Memorial Hospital, Miami, FL
¹⁶Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹⁷Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹⁸Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Yizhen Liu, MD, PhD^1*, Lingyu Liu^2*, Chuanxu Liu, MD, PhD^1*, Wenhao Zhang^1*, Shiyu Jiang^1*, Qunling Zhang^1*, Fangfang Lyu^1*, Xiaojian Liu^1*, Junning Cao¹, Xuejun Ma^1* and Rong Tao^1*

¹Fudan University Shanghai Cancer Center, Shanghai, China
²Fudan University Cancer Hospital Xiamen Hospital, Xiamen, China

Ryan Low, BSc, MBBS, MRCP^1*, Andrew Warden^2*, Michelle Postek^3*, Peter Denardis^3*, Charalampia Kyriakou, MD, PhD⁴, Adam J. Olszewski, MD⁵, Marie José Kersten^6*, Josephine M.I. Vos^7*, Sheeba K. Thomas, MD⁸, Shirley D'Sa, FRCP FRCPath MD(Res)^9*, Newton Guerin^3*, Carl Harrington^3*, Judith Trotman, FRACP¹⁰ and Ibrahim Tohidi-Esfahani, MBBS, FRACP, FRCPA¹⁰

¹Concord Repatriation General Hospital, University of Sydney, London, ENG, United Kingdom
²Wmozzies, Australian Patient Support Group For WM, Concord, AUS
³International Waldenström's Macroglobulinemia Foundation, Sarasota, FL
⁴UCLH Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Brown University, Providence, RI
⁶Cancer Center Amsterdam, Amsterdam, Netherlands
⁷Amsterdam UMC, University of Amsterdam & Sanquin, Amsterdam, Netherlands
⁸Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁰Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia

Ahmed Sawas, MD^1,2, Niquelle Brown Wadé^3* and James Roose^3*

¹Flatiron Health Inc., New York, NY
²Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
³Flatiron Health, New York, NY

Yuhan Gao^1*, Siyuan Li^2*, Yue Dang^2*, Minghui Duan^2*, Jian Li, MD² and Lu Zhang, MD^1*

¹Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
²Department of Hematology, Peking Union Medical College Hospital, Beijing, China

Benoit Tessoulin, MD, PhD^1,2*, Franck Morschhauser, MD, PhD³, David Chiron, PhD^4*, Krimo Bouabdallah, MD^5*, Guillaume Cartron, MD, PhD^6*, Cedric Rossi, MD, PhD⁷, Caroline Milin, MD, PhD^8*, Ludovic Fouillet, MD^9*, Charles Herbaux, MD, PhD^10*, Emmanuelle Tchernonog^11*, Rory McCulloch, FRCPath, MRCP, MBBS^12*, Thomas Gastinne, MD^13*, Mary B. Callanan, PhD^14* and Steven Le Gouill, MD, PhD¹⁵

¹CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
²Department of hematology, Nantes university hospital, Nantes, France
³Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁴CRCI²NA - Nantes - Angers Cancer and Immunology Research Center, Nantes, NY, France
⁵Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
⁶Centre Hospitalier Universitaire de Montpellier, Montpellier, France
⁷CHU Dijon, DIJON, France
⁸Department of Nuclear Medicine, University Hospital of Nantes, Nantes, France
⁹Hematology department, CHU, Saint-Etienne, France
¹⁰Department of Hematology, Montpellier university hospital, Montpellier, France
¹¹Hematology Department, CHU Montpellier, Montpellier Cedex 5, France
¹²Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom
¹³Centre Hospitalier Universitaire de Nantes, Nantes, France
¹⁴CHU de Dijon, Université de Bourgogne, Dijon, France
¹⁵Institut Curie, Saint-Cloud, France

Ángel Serna, MD^1*, Marc Bosch^1*, Victor Navarro Garces, BSc^2*, Patricia Lopez Pereira^3*, David Quintela^4*, Juan-Manuel Sancho, MD, PhD^4*, Adolfo Jesús Sáez Marín, MD^5*, Ana Jiménez Ubieto^6*, Alberto López^7*, Raul Cordoba, MD, PhD⁸, Maria Cerdá^9*, Beatriz De La Cruz^10*, Samuel Romero^11*, Ainara Ferrero^12*, Tomas Garcia Cerecedo^12*, Teresa Villalobos^13*, Andrea Rivero, MD^14*, Cristina García, MD^15*, Ana Marín Niebla^16*, Gloria Iacoboni, MD^15*, Francesc Bosch, MD, PhD¹⁷ and Pau Abrisqueta Costa, MD, PhD^17*

¹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
²Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
³Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, HOSPITALET, Spain
⁴ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
⁵Servicio de Hematología, Hospital 12 de Octubre, Madrid, Madrid, Spain
⁶Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁷Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
⁸Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁹ICO-Hospital Josep Trueta, Gerona, Spain
¹⁰Hematology Department, Hospital Universitario La Paz, Madrid, Spain
¹¹Hospital Universitari i Politècnic La Fe, Valencia, Spain
¹²University Hospital Arnau de Vilanova, Lleida, Spain
¹³Hematology Department, Hospital Mutua de Terrassa, Terrassa, Spain
¹⁴Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
¹⁵Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹⁶Department of Hematology University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹⁷Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Yeokyeong Shin^1*, Jaewon Hyung, MD^2*, Hyungwoo Cho^2*, Shin Kim^2*, Chan-Sik Park, MD, PhD^3*, Heounjeong Go^3*, In Hye Song^3*, Jin-Sook Ryu^4*, Sang-wook Lee^5* and Dok Hyun Yoon, MD, PhD²

¹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
²Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁵Depertment of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Sebastian Giebel, MD, PhD^1*, Anna Czyz^2*, Iwona Hus, MD^3*, Lidia Gil, MD, PhD⁴, Krzysztof Giannopoulos, MD, PhD^5*, Joanna Romejko-Jarosinska^6*, Maciej Majcherek^7*, Agnieszka Szeremet^8*, Anna Wache^9*, Paulina Kwasnik^10*, Wlodzimierz Mendrek^11* and Wojciech Jurczak, MD, PhD¹²

¹Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
²Deaprtment of Hematology, Medical University of Wroclaw, Wroclaw, Poland
³ul. Wołoska 137, The National Institute of Medicine of the Ministry of Interior and Administration, Warszawa, Poland
⁴Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
⁵Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
⁶Maria Sklodowska-Curie Institute - Oncology Centre, Warsaw, Poland
⁷Medical University of Wroclaw, Wroclaw, Poland
⁸Wroclaw Medical University, Wroclaw, Poland
⁹Poznan University of Medical Sciences, Poznan, Poland
¹⁰Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland
¹¹Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
¹²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland

Anubhuti Sharma, MD^1*, Arundhati Sharma^2*, Simranpreet Singh Daid, MBBS^3*, Vagisha Sharma^4*, Akriti Agrawal, MD^5*, Adishwar Rao, MD^5* and Joyson Poulose, MD⁶

¹Guthrie/Robert Packer Hospital, Sayre, PA
²MAYO clinic, ARIZONA, AZ
³PIMS, JALANDHAR, Abohar, India
⁴GUTHRIE/ROBERT PACKER HOSPITAL, New Delhi, India
⁵GUTHRIE/ROBERT PACKER HOSPITAL, Sayre
⁶Guthrie Robert Packer Hospital, Sayre, PA

Hui-Peng Lee, MD^1*, Stephen S. Opat, MBBS, FRACP, FRCPA², John Hrom^3*, David Kliman, MBBS, FRACP, FRCPA^4*, Paula Marlton^5*, Peng Liu, MD⁶, Chenmu Du^7*, Amber Lussier^8*, Jun Zhang^8*, Haiyi Guo^9* and Steven P. Treon, MD, PhD, FRCP¹⁰

¹Flinders Medical Centre, Adelaide, Australia
²Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
³Hattiesburg Clinic, Hattiesburg, MS
⁴GenesisCare North Shore, St Leonards, NSW, Australia
⁵Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia
⁶Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
⁷BeiGene (Beijing) Co, Ltd, Beijing, China
⁸BeiGene USA, Inc, San Mateo, CA
⁹BeiGene (Shanghai) Co, Ltd, Shanghai, China
¹⁰Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Carrie I Ho, MD^1,2, Mengyang Di, MD, PhD^1,2, Ryan C Lynch, MD^1,2, Christina Poh, MD^1,2, Vikram Raghunathan, MD^1,2*, Mazyar Shadman, MD, MPH^1,2, Stephen D. Smith, MD^1,2, Brian G. Till, MD^2,3, Paul S Martin, MD^1,2, Chaitra S. Ujjani, MD^1,2 and Ajay K. Gopal, MD^1,2

¹Fred Hutchinson Cancer Center, Seattle, WA
²Division of Hematology and Oncology, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Center, University of Washington, Seattle, WA

Anne W Beaven, MD¹, Susan M. Geyer, PhD², Jonathon B. Cohen, MD, MS³, Tycel Phillips, MD^4*, Travis Dockter^2*, Priyanka A. Pophali, MD⁵, Gita Thanarajasingam, MD⁶, Gina L. Mazza, PhD^7*, Alvaro J Alencar, MD⁸, Shira N. Dinner, MD⁹, Eric D. Hsi, MD¹⁰, Meng Welliver, MD^11*, Daniel Nikcevich, MD, PhD¹², Brad S. Kahl, MD¹³, Jonathan W. Friedberg, MD¹⁴, Nancy L. Bartlett, MD¹⁵ and John P. Leonard, MD¹⁶

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
³Winship Cancer Institute, Emory University, Atlanta, GA
⁴City of Hope, Duarte, CA
⁵Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
⁸Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
⁹Alliance Protocol Operations Office, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
¹⁰Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹¹Mayo Clinic, Rochester, MN
¹²Essentia Health Cancer Center, Duluth, MN
¹³Department of Medicine, Washington University School of Medicine, St. Louis, MO
¹⁴Wilmot Cancer Center, University of Rochester, Rochester, NY
¹⁵Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
¹⁶Weill Cornell Medicine, New York, NY